The main clinical concern is that rapid weight loss may alter how much thyroid hormone your body needs, potentially requiring dose adjustments during the first months of treatment
From improved glycemic control and weight management to cardiovascular benefits, blood pressure regulation, and potential impacts on liver health, neuroprotection, and gastrointestinal function, semaglutide represents a multifaceted treatment option
The drug should emerge as a first-line therapy for persons with type 2 diabetes and associated overweight/obesity as well as atherosclerotic cardiovascular disease
If the pattern follows other incretin therapies, weight regain after cessation is likely
While compounded drugs are legal, they do not undergo pre-market approval from the FDA as they are not made in large batches for the public, compounds are made based on specific orders from a medical professional